Vaxart, Inc. (VXRT) P/E Ratio History
Deep ValueTrading at 7.9x · 10th percentile of 5-year range · Significant discount to historical valuation · Data 1990–2026
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Vaxart, Inc. (VXRT) trades at a price-to-earnings ratio of 7.9x, with a stock price of $0.55 and trailing twelve-month earnings per share of $0.15.
The current P/E is 99% below its 5-year average of 957.5x. Over the past five years, VXRT's P/E has ranged from a low of 4.3x to a high of 7458.0x, placing the current valuation at the 10th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, VXRT trades at a 64% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, VXRT trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our VXRT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
VXRT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
VXRT P/E vs Peers
Vaccines and Infectious Disease peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 3.6Lowest | - | +307% | |
| $143B | 18.5 | - | -4% | |
| $102B | 18.2 | - | -7% | |
| $102B | 6.9 | 0.49Best | +348%Best | |
| $281B | 15.6 | 0.74 | +8% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
VXRT Historical P/E Data (1990–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $0.60 | $0.14 | 4.3x | -99% |
| FY2025 Q4 | Dec 31 2025 | $0.35 | $0.05 | 6.8x | -99% |
| FY2010 Q4 | Dec 25 2010 | $372.90 | $0.05 | 7458.0x | +1247% |
| FY2010 Q3 | Sep 25 2010 | $326.70 | $1.16 | 282.1x | -49% |
| FY2008 Q3 | Sep 27 2008 | $329.34 | $7.50 | 43.9x | -92% |
| FY2008 Q2 | Jun 28 2008 | $269.94 | $6.01 | 44.9x | -92% |
| FY2008 Q1 | Mar 29 2008 | $250.14 | $5.54 | 45.1x | -92% |
| FY2007 Q4 | Dec 29 2007 | $248.82 | $5.13 | 48.5x | -91% |
| FY2003 Q3 | Sep 27 2003 | $542.52 | $0.09 | 5771.5x | +942% |
| FY2003 Q1 | Mar 29 2003 | $399.30 | $0.53 | 747.8x | +35% |
| FY2002 Q4 | Dec 28 2002 | $413.16 | $0.33 | 1252.0x | +126% |
| FY2002 Q3 | Sep 28 2002 | $357.72 | $0.38 | 941.4x | +70% |
| FY2002 Q2 | Jun 29 2002 | $312.18 | $15.10 | 20.7x | -96% |
| FY2002 Q1 | Mar 30 2002 | $406.56 | $15.23 | 26.7x | -95% |
| FY2001 Q4 | Dec 29 2001 | $726.00 | $15.47 | 46.9x | -92% |
| FY2001 Q3 | Sep 29 2001 | $407.88 | $15.75 | 25.9x | -95% |
| FY2001 Q2 | Jun 30 2001 | $524.04 | $0.81 | 649.4x | +17% |
| FY2001 Q1 | Mar 31 2001 | $408.38 | $0.81 | 506.0x | -9% |
| FY2000 Q4 | Dec 30 2000 | $305.25 | $0.81 | 378.3x | -32% |
| FY2000 Q3 | Sep 30 2000 | $462.00 | $0.54 | 850.8x | +54% |
| FY2000 Q2 | Jul 01 2000 | $482.63 | $0.90 | 538.6x | -3% |
| FY2000 Q1 | Apr 01 2000 | $445.50 | $0.83 | 536.7x | -3% |
| FY1999 Q4 | Dec 31 1999 | $305.25 | $0.60 | 506.2x | -9% |
| FY1997 Q3 | - | $482.63 | $1.00 | 481.2x | -13% |
| FY1997 Q2 | Jun 30 1997 | $437.25 | $2.72 | 160.8x | -71% |
| FY1997 Q1 | Mar 31 1997 | $449.63 | $2.65 | 169.5x | -69% |
| FY1996 Q4 | - | $577.50 | $2.49 | 232.3x | -58% |
| FY1995 Q3 | Sep 30 1995 | $544.50 | $4.02 | 135.3x | -76% |
| FY1995 Q2 | Jun 30 1995 | $618.75 | $3.69 | 167.5x | -70% |
| FY1995 Q1 | Mar 31 1995 | $577.50 | $3.36 | 171.7x | -69% |
| FY1994 Q4 | Dec 31 1994 | $495.00 | $3.03 | 163.2x | -71% |
| FY1994 Q3 | Sep 30 1994 | $470.25 | $2.82 | 166.7x | -70% |
| FY1994 Q2 | - | $416.63 | $2.49 | 167.3x | -70% |
| FY1994 Q1 | - | $387.75 | $2.10 | 185.1x | -67% |
| FY1993 Q4 | Dec 31 1993 | $218.63 | $1.63 | 133.9x | -76% |
| FY1993 Q3 | - | $222.75 | $0.80 | 277.4x | -50% |
| FY1992 Q3 | Sep 30 1992 | $243.38 | $0.29 | 851.0x | +54% |
| FY1992 Q2 | - | $239.25 | $1.08 | 221.9x | -60% |
| FY1992 Q1 | - | $259.88 | $1.08 | 241.1x | -56% |
| FY1991 Q4 | - | $218.63 | $0.96 | 227.3x | -59% |
| FY1991 Q3 | Sep 30 1991 | $94.88 | $0.91 | 104.8x | -81% |
| FY1991 Q2 | Jun 30 1991 | $84.56 | $0.97 | 87.1x | -84% |
| FY1991 Q1 | Mar 31 1991 | $107.25 | $0.97 | 110.5x | -80% |
| FY1990 Q4 | Dec 31 1990 | $61.88 | $0.97 | 63.7x | -88% |
| FY1990 Q3 | Sep 30 1990 | $90.75 | $0.87 | 104.6x | -81% |
| FY1990 Q2 | Jun 30 1990 | $90.75 | $0.79 | 115.5x | -79% |
Average P/E for displayed period: 553.7x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
36+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VXRT — Frequently Asked Questions
Quick answers to the most common questions about buying VXRT stock.
What is VXRT's P/E ratio?
Vaxart, Inc. (VXRT) trailing twelve-month P/E ratio is 7.9x, based on TTM diluted EPS of $0.15. The 5-year average P/E is 957.5x and the historical range spans 4.3x to 7458.0x.
Is VXRT stock overvalued or undervalued?
VXRT trades at 7.9x P/E, below its 5-year average of 957.5x. At the 10th percentile of its historical range (4.3x–7458.0x), the stock is priced at a discount to its own history.
Is VXRT stock expensive?
No, VXRT is not expensive on a historical basis. The current P/E of 7.9x is below the 5-year average of 957.5x and sits at the 10th percentile of its valuation range.
What is VXRT's historical P/E range?
Over the past 5 years, VXRT's P/E ratio has ranged from 4.3x to 7458.0x, with a median of 282.1x and an average of 957.5x. The current P/E of 7.9x places the stock at the 10th percentile of this range. Full historical data spans 1990–2026.
How does VXRT's P/E compare to the S&P 500?
VXRT trades at 7.9x P/E versus the S&P 500 median of 24.4x. The 68% discount to the market suggests lower growth expectations or perceived higher risk.
How does VXRT's valuation compare to Healthcare peers?
Vaxart, Inc. P/E of 7.9x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is VXRT's PEG ratio?
VXRT PEG ratio is N/A, based on a P/E of 7.9x and EPS growth of 150.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is VXRT's earnings yield?
VXRT earnings yield is 12.70%, the inverse of its 7.9x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.